Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech graveyard
Biotech
Third Harmonic’s song to end as biotech looks to liquidate
Third Harmonic has abandoned plans to take its urticaria drug into phase 2, instead preparing to sell the asset while liquidating the business.
James Waldron
Apr 14, 2025 9:01am
Vincerx prepares to wind down as final merger attempt collapses
Apr 9, 2025 7:55am
A look inside biopharma’s Q1: 8 closures and 63 layoff waves
Apr 1, 2025 9:00am
Carisma winds down operations, lays off 95% of remaining staff
Apr 1, 2025 7:20am
Cancer biotech Inspirna winding down
Apr 1, 2025 3:50am
Langer spinout Lyndra begins winding down, lays off staff
Mar 27, 2025 10:58am